FDA Pre-emption Wins On Appeal, But Coming Supreme Court Case May Mean More For Drug Liability Risks
This article was originally published in The Pink Sheet Daily
Executive Summary
Third Circuit Court of Appeals tosses failure-to-warn claims against GSK and Pfizer.